Skip to content Skip to footer
Midostaurin: Benefits, Reviews, Info, Side Effects!
Rx Details
Midostaurin
PKC412, Rydapt
Midostaurin
Prescription
Drug
Drugs
Prescription Only
treatment of acute myeloid leukemia, treatment of advanced systemic mastocytosis, inhibition of multiple kinases, potential to improve survival rates, potential to reduce disease progression
Abdominal Pain, Anemia, Constipation, Cough, Decreased Appetite, Diarrhea, Dizziness, Edema, Fatigue, Fever, Headache, Joint Pain, Muscle Pain, Nausea, Neutropenia, Rash, Thrombocytopenia, Upper Respiratory Tract Infection, Vomiting
Midostaurin is typically used in the treatment of certain types of cancer, such as acute myeloid leukemia (AML) and advanced systemic mastocytosis. The average dosage can vary based on the specific condition being treated and the patient’s individual circumstances. For AML, the usual dosage of midostaurin is 50 mg taken orally twice daily. It is often administered in combination with standard chemotherapy during the induction and consolidation phases of treatment. For advanced systemic mastocytosis, the typical dosage is 100 mg taken orally twice daily. It’s important to note that these dosages are general guidelines and the actual prescribed dosage may differ. Patients should always follow their healthcare provider’s instructions regarding dosage and administration.
Acute myeloid leukemia, systemic mastocytosis
Midostaurin has a generally favorable safety profile.
No Interactions Reported
$1,500 – $2,000
$14,000 for a 30day supply.

A Synopsis of

Midostaurin

Midostaurin is a medication that belongs to a class of drugs known as kinase inhibitors. It is primarily used in the treatment of certain types of blood cancers, such as acute myeloid leukemia (AML) and mastocytosis.

This medication works by targeting specific enzymes in cancer cells that are responsible for their growth and proliferation. By inhibiting these enzymes, Midostaurin helps to slow down the progression of the disease and improve outcomes for patients.

It is important to note that Midostaurin should only be taken under the supervision of a healthcare provider who is experienced in the treatment of blood cancers. They will be able to determine the appropriate dosage and monitor for any potential side effects.

Common side effects of Midostaurin may include nausea, vomiting, diarrhea, fatigue, and low blood cell counts. It is important to report any side effects to your healthcare provider so that they can be properly managed.

It is also important to inform your healthcare provider about any other medications or supplements you are taking, as they may interact with Midostaurin and affect its effectiveness.

Overall, Midostaurin is a valuable treatment option for patients with certain types of blood cancers. It has shown promising results in clinical trials and continues to be an important tool in the fight against these diseases. If you have been prescribed Midostaurin, be sure to follow your healthcare provider’s instructions carefully and reach out to them with any questions or concerns.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN